Pharmaceutical Technology
APRIL 24, 2024
Pfizer and its Germany partner BioNTech have urged London’s High Court to invalidate competitor Moderna's patents over technology instrumental in the Covid-19 vaccines development as the latest phase of a global legal fight that started yesterday (23 April), reported Reuters.
Bio Pharma Dive
APRIL 24, 2024
Growing demand has convinced Biogen that it's worth expanding the sales force around Leqembi by 30%.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuroBlog - Aurous Healthcare Clinical Trials blog
APRIL 24, 2024
The constant ebb and flow of hormones that guide the menstrual cycle don’t just affect reproductive anatomy. They also reshape the brain, and a study has given us insight into how this happens.
Bio Pharma Dive
APRIL 24, 2024
An expanded partnership with OpenAI is helping Moderna embed custom-built AI chatbots in a wide range of research and business processes.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
AuroBlog - Aurous Healthcare Clinical Trials blog
APRIL 24, 2024
Positive outcomes with brain pacemakers & NeuroSmart Portable MER (micro-electrode recording) system have paved the way for improved treatments in Parkinson’s disease.
Bio Pharma Dive
APRIL 24, 2024
First quarter sales of Zurzuvae doubled consensus estimates, though analysts are skeptical whether the better-than-expected launch will continue.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Bio Pharma Dive
APRIL 24, 2024
While the company is eager to diversify, CEO Chris Viehbacher said that in the near-term any dealmaking would likely focus on collaborations and early-stage assets.
Pharmaceutical Technology
APRIL 24, 2024
At the Swiss Biotech Day conference, panelists at an investment talk discussed the current state of the Swiss investment landscape.
Bio Pharma Dive
APRIL 24, 2024
Led by the founder of a biotech Celgene acquired for $7 billion, the startup is developing two prospects that originated in the labs of other drugmakers.
Pharmaceutical Technology
APRIL 24, 2024
Lutathera is approved by the US FDA to treat patients aged 12 years and older with rare gastroenteropancreatic neuroendocrine cancer.
Bio Pharma Dive
APRIL 24, 2024
The mRNA vaccine maker, which has lost most of its value since early 2021, is undergoing an “organizational redesign” that will involve the elimination of 150 positions.
Pharmaceutical Technology
APRIL 24, 2024
Discover how MacroGenics Inc's patent for compounds targeting IL23A and BAFF can suppress inflammatory responses in subjects in need. Learn about the unique polypeptide compositions and methods outlined in the patent.
Bio Pharma Dive
APRIL 24, 2024
In this three-part podcast series, hear from seasoned experts from Allucent as they discuss a range of topics, including how small and mid-sized companies can take a more strategic approach to pharmacovigilance, a regulatory & development roadmap for ADCs and RDCs, and pre-MAA/NDA inspection readiness.
Pharmaceutical Technology
APRIL 24, 2024
Discover how BioCryst Pharmaceuticals' patent for complement system inhibitors offers targeted treatment options for diseases like paroxysmal nocturnal hemoglobinuria.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
pharmaphorum
APRIL 24, 2024
A new FDA initiative is seeing how augmented reality and virtual reality (AR/VR) can make patients’ own homes an integral part of the healthcare system
Pharmaceutical Technology
APRIL 24, 2024
Discover the groundbreaking patent by Seres Therapeutics Inc for a unique composition targeting dysbiosis in mammals. Learn how specific bacterial species in a capsule can inhibit pathogenic bacteria growth.
Fierce Pharma
APRIL 24, 2024
It’s been eight months since Regeneron secured approval for a high-dose version of its powerhouse macular degeneration treatment Eylea in the U.S. | How much impact has the approval of high-dose Eylea had on the upward trajectory of Roche’s Vabysmo? Not much, according to sales figures released by Roche.
Pharmaceutical Technology
APRIL 24, 2024
Discover how Ipsen SA's patented compounds can treat cardiovascular, metabolic, gastrointestinal, and liver diseases. Learn about the method and specific compounds outlined in the recently granted patent.
pharmaphorum
APRIL 24, 2024
Explore the emergence of ADCs as the "hot, new technology" in the biopharmaceutical industry with companies like ImmunoGen, acquisitioned by AbbVie leading the way. Understand the potential of antibody-drug conjugates and their impact on innovative therapies.
Pharmaceutical Technology
APRIL 24, 2024
Enhance medication dosing accuracy with Sanofi's patented optical decoding system for drug delivery devices. Improve efficiency and precision in dispensing with this innovative technology.
pharmaphorum
APRIL 24, 2024
Explore the concept of embracing a future-ready pharmacovigilance ecosystem and discover how advancements in technology and regulations are shaping the future of drug safety monitoring.
Pharmaceutical Technology
APRIL 24, 2024
Discover the groundbreaking patent by Bicycle Therapeutics Plc for high affinity binders of Nectin-4, including drug conjugates and pharmaceutical compositions. Learn about the detailed method for synthesizing compound BCY8245.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharma Times
APRIL 24, 2024
According to the World Health Organization, CVDs are responsible for an estimated 17.
Pharmaceutical Technology
APRIL 24, 2024
Discover how Pfizer's patented CARs targeting BCMA offer a groundbreaking method for treating cancer. Learn about the unique ligand-binding and signaling domains for effective treatment.
Rethinking Clinical Trials
APRIL 24, 2024
Dr. Lauren Milner, Dr. Jonathan Casey, and Dr. Matthew Semler In this Friday's PCT Grand Rounds, Lauren Milner of the US Food and Drug Administration (FDA) and Jonathan Casey and Matthew Semler of Vanderbilt University will present "Waiver or Alteration of Informed Consent for Minimal Risk Clinical Investigations – FDA Regulation Development and Research Landscape.
Pharmaceutical Technology
APRIL 24, 2024
The EC has granted approval for label extension to Astellas’ Xtandi to be used as monotherapy or in combination with androgen deprivation therapy to treat adult men with high-risk BCR nmHSPC who are not suitable for salvage-radiotherapy.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Fierce Pharma
APRIL 24, 2024
While Biogen’s Chris Viehbacher figures the company is “turning the corner” after several recent setbacks—thanks in large part to accelerating launches of new drugs like Leqembi and Skyclarys—the C | While Biogen’s Chris Viehbacher figures the company is “turning the corner” after several recent setbacks, the CEO admitted Wednesday that there’s still “a lot of work to do” as the biotech plugs ahead with its “Fit for Growth” savings initiative.
Pharmaceutical Technology
APRIL 24, 2024
GSK, Lundbeck, and ROVI share how their events strategies contribute to higher-value engagement with healthcare professionals (HCPs).
pharmaphorum
APRIL 24, 2024
An oral therapy that can allow children and adolescents with an aggressive form of brain cancer to be treated at home rather than in hospital has been recommended for use by the NHS in England and Wales.
Pharmaceutical Technology
APRIL 24, 2024
As awareness surrounding social prescribing grows, can this initiative go hand in hand with the pharmaceutical industry?
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
325 
Let's personalize your content